Carl Johan Friddle
Lexicon Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Carl Johan Friddle.
PLOS ONE | 2009
Indrani Rajan; Katerina V. Savelieva; Gui-Lan Ye; Ching-yun Wang; Murtaza M. Malbari; Carl Johan Friddle; Thomas H. Lanthorn; Wandong Zhang
Histone deacetylase 4 (HDAC4) has been associated with muscle & bone development [1]–[6]. N-terminal MEF2 and RUNX2 binding domains of HDAC4 have been shown to mediate these effects in vitro. A complete gene knockout has been reported to result in premature ossification and associated defects resulting in postnatal lethality [6]. We report a viral insertion mutation that deletes the putative deacetylase domain, while preserving the N-terminal portion of the protein. Western blot and immuno-precipitation analysis confirm expression of truncated HDAC4 containing N-terminal amino acids 1-747. These mutant mice are viable, living to at least one year of age with no gross defects in muscle or bone. At 2–4 months of age no behavioral or physiological abnormalities were detected except for an increased latency to respond to a thermal nociceptive stimulus. As the mutant mice aged past 5 months, convulsions appeared, often elicited by handling. Our findings confirm the sufficiency of the N-terminal domain for muscle and bone development, while revealing other roles of HDAC4.
Archive | 2001
Carl Johan Friddle; Brenda Gerhardt
Archive | 2001
Carl Johan Friddle; Brenda Gerhardt; Yi Hu
Archive | 2002
Yi Hu; Boris Nepomnichy; Brenda Gerhardt; D. Wade Walke; Carl Johan Friddle
Archive | 2002
Carl Johan Friddle; Brenda Gerhardt
Archive | 2001
Carl Johan Friddle; Brenda Gerhardt
Archive | 2001
Carl Johan Friddle; Brenda Gerhardt; Erin Hilbun; C. Turner
Archive | 2004
Carl Johan Friddle; Brenda Gerhardt
Archive | 2002
Carl Johan Friddle; Yi Hu; Brian Mathur; Boris Nepomnichy; C. Alexander Turner
Archive | 2001
Carl Johan Friddle; Brenda Gerhardt